Board and management

Education and professional experience: Claus holds an M.Sc. from Copenhagen Business School, Denmark, and an MBA in Strategy and Finance from the UCLA Anderson School of Management. He was CEO of Atos Medical from early 2014 through to the end of 2018. Atos Medical was sold by EQT to PAI Partners during his tenure in 2016. From 2006 to 2014, Claus held numerous senior leadership positions in Coloplast A/S, a Danish global consumable Medtech company, most recently as President - North America, Japan, and Australia. Before joining Coloplast, Claus spent 10 years within corporate strategy, mergers and acquisitions, and private equity across industries working for McKinsey & Company, Nordic Capital, and Mattel.

Other current engagement: Claus is currently Senior Advisor to KKR & Co. Inc. and Managing Director of Eden Invest LLC.

Shareholding in Sedana Medical: 0 shares. Independent in relation to the company, its management, and the company´s major shareholders.

Education and professional experience: Hilde Furberg has an M.Sc. in Chemistry from Oslo University, Norway. Hilde is an independent consultant and professional Board member. She has extensive leadership experience from her 35 years in sales, marketing, strategy, and management within Pharma/Biotech, from both small and large global companies. Hilde has worked operationally in companies such as Genzyme and Baxter, most recently as Senior Vice President EMEA Rare Diseases at Sanofi Genzyme. In addition, Hilde has experience from positions as Board member in BerGenBio, Probi, Pronova, Clavis, Algeta, Tappin, and CombiGene and as Chairman of the Board of directors in Blueprint Genetics.

Other current engagement: Industrial Advisor to Investinor, as well as Board member in PCI Biotech, Calliditas Therapeutics, OncoZenge, Bio-Me, and Herantis.

Shareholding in Sedana Medical: 1,500 shares. Independent in relation to the Company and its management and in relation to major shareholders.

Education and professional experience: Ola holds an upper secondary school qualification in engineering specialising in chemistry from Gothenburg Technical Upper Secondary School, Sweden. Ola has more than 25 years of experience in the pharmaceutical industry mainly in marketing, sales, and different management positions including 4 years in the US for Pharmacia in the 1980s and 1990s. Ola also has more than 20 years of experience in the Medtech industry as CEO of Louis Gibeck AB where he was responsible for the company´s listing on the OTC exchange in Stockholm and as Managing Director EMEA at Hudson RCI AB after its acquisition of Louis Gibeck AB. Ola was the founder of Sedana Medical in 2005 and served as CEO until 2011.

Other current engagement: Chairman of the Board of Eataway AB. Member of the Board of TransCutan AB and Board member in small family companies.

Shareholding in Sedana Medical: 4,462,098 shares privately and via Magiola Consulting AB. Independent in relation to the company, its management, and the company´s major shareholders.

Education and professional experience: Christoffer holds an M.Sc. from Chalmers University of Technology and a master´s degree in economics from the School of Business and Economics at the University of Gothenburg, Sweden. During the period 2012-2020 he was CFO of XVIVO Perfusion AB. During the period 2015–2017, he led XVIVO’s North American operations and resided in the United States. From 2001 to 2012, he held leading positions in finance and strategic management at Novartis and LG Electronics.

Other current engagement: CEO (since 2022) at XVIVO Perfusion AB.

Shareholding in Sedana Medical: 10,000 shares. Independent in relation to the company, its management, and the company´s major shareholders.

Education and professional experience: Eva holds a B.Sc. from the School of Economics in Gothenburg, Sweden. Over 20 years of experience in the pharmaceutical and Medtech industries, mainly in marketing and sales as well as corporate management. Formerly VP Commercial Operations, International Region at Phadia / ThermoFisher Scientific, as well Strategic Affairs Director at Johnson & Johnson Nordic AB, Medical Device and Strategic Development Manager at Pfizer AB.

Other current engagement: Vice President Marketing at Olink Proteomics AB, Member of the Board of Senzime AB since 2020, CEO and Chairman of the Board of her own company Movits Consulting AB and deputy member of the board of Finnson & Partners AB.

Shareholding in Sedana Medical: 12,800 shares. Independent in relation to the company, its management, and the company´s major shareholders.

Education and professional experience: Johannes holds an MBA, from the University of Texas, and Dipl. Kaufmann, WHU Otto Beisheim School of Management, Germany. From 2013-2021, Johannes was part of the Executive Management team at Orexo AB, most recently as Executive Vice President and Chief Commercial Officer. Prior to joining Orexo, Johannes worked at McKinsey & Company from 2004 to 2013, advising international clients in the pharmaceutical and medical devices industry and the private equity sector.

Shareholding in Sedana Medical: 17,630 shares and 495,000 warrants.

Education and professional experience: Peter holds an M.Sc. from the Royal Institute of Technology (KTH) in Stockholm, Sweden. More than 20 years of experience in product and business development, as a product manager at Elekta Instrument AB and as a consultant within Life Science.

Shareholding in Sedana Medical: 0 shares and 30,000 warrants.

Education and professional experience: Stefan holds an M.Sc. in Mechanical Engineering from the Royal Institute of Technology (KTH) Stockholm, Sweden, and TUD Darmstadt, Germany. In addition, he studied business administration and management at Stockholm Business School, Stockholm University. Stefan has around 20 years of experience in leading positions in various industries, principally in manufacturing, logistics, and business development. Former CEO of Svensk Dos AB, CEO of Dipylon Medical AB, and Production Manager at AB Gustavsberg. Founder of Eker Bicycles AB and Eker Production Ltd., Uganda.

Other current engagement: Chairman of the Board Eker Bicycles AB and Eker Production Ltd., Uganda. Owner K-Consulting (sole proprietor).

Shareholding in Sedana Medical: 5,600 shares and 74,400 warrants.

Education and professional experience: Clarisa holds an MBA, from Heriot-Watt University, Scotland. Most recently, she acted as Sr VP Sales and Marketing at 3C Carbon Group AG as well as member of the Management team. From 2012-2021, Clarisa was part of the Executive Management team at Stille AB where she acted as VP Sales & Marketing as well as General Manager with Global account ownership for Philips, Siemens, Getinge, and GE Healthcare. Previously, Clarisa worked at Philips Healthcare from 2009-2011, in various positions.

Shareholding in Sedana Medical: 0 shares.

Education and professional experience: Peter received his doctor´s degree from Karolinska Institutet, Stockholm, in 1997. Before joining Sedana Medical, he worked for twenty years at the Department of Perioperative Medicine and Intensive Care, Karolinska University Hospital, and is Board-certified in Anesthesiology (DESA) and Intensive Care (EDIC). He completed his Ph.D. thesis entitled “Isoflurane sedation in Intensive Care Unit patients” at Karolinska Institutet in 2006. He is an Associate professor at Karolinska Institutet, has supervised several Ph.D. students in ICU sedation, pain monitoring, and long-term outcomes research, and remains active in ICU-related research. Previous positions: Senior Consultant, Head of Neurocritical Care, Department of Perioperative Medicine and Intensive Care, Karolinska University Hospital.

Other current engagement: Associate professor, Department of Physiology and Pharmacology, Karolinska Institutet.

Shareholding in Sedana Medical: 187,468 shares and 69,073 warrants.

Education and professional experience: Johan holds an M.Sc. in Economics and Business Administration from the Stockholm School of Economics (Handelshögskolan). Over the period 2013-2021, Johan worked at the investment bank Pareto Securities, of which 2015-2021 as partner and Head of Equity Research in Stockholm. Prior to joining Pareto Securities, Johan worked as a financial analyst at Goldman Sachs in London and New York, 2009 - 2013.

Shareholding in Sedana Medical: 15,073 shares and 69,073 warrants.

Education and professional experience: Karolina has a law degree from Stockholm University. Karolina has been active as a legal counsel in the pharmaceutical industry for more than 15 years. Prior to joining Sedana Medical, Karolina worked at Oncopeptides as General Counsel. Previously, Karolina has worked at Gilead Sciences, Biovitrum, and Swedish Orphan Biovitrum (Sobi) in various positions in Legal Affairs.

Shareholding in Sedana Medical: 0 shares.

Education and professional experience: Jessica holds an M.Sc. in Analytical Chemistry at Umeå University, Sweden. She is a former employee at Unimedic AB (2006-2020) as Head of Quality and Product Development, and before that at AstraZeneca (1998-2006).

Shareholding in Sedana Medical: 0 shares and 18,260 warrants. Related parties 692 shares.